scholarly journals Improving respiratory outcomes after pediatric cardiac surgery: new uses for nitric oxide.

2021 ◽  
Author(s):  
Jacques Scharoun
Keyword(s):  
Nitric Oxide ◽  
Respiratory Failure ◽  
High Frequency ◽  
Heart Surgery ◽  
Congenital Heart Surgery ◽  
Surgical Patients ◽  
Improved Outcomes ◽  
Frequency Oscillator ◽  
Hypoxic Respiratory Failure ◽  
Respiratory Outcomes

Nitric oxide has been used to treat respiratory failure in post-pediatric cardiac surgical patients. High frequency oscillator ventilation is used to rescue infants who have failed conventional ventilation. In this issue a study is presented showing the benefit of combining these two therapies for improved outcomes in infants with hypoxic respiratory failure after congenital heart surgery

Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study

The Lancet ◽  
2000 ◽  
Vol 356 (9240) ◽  
pp. 1464-1469 ◽  
Author(s):  
Owen I Miller ◽  
Swee Fong Tang ◽  
Anthony Keech ◽  
Nicholas B Pigott ◽  
Elaine Beller ◽  
...  
Keyword(s):  
Nitric Oxide ◽  
Pulmonary Hypertension ◽  
Congenital Heart ◽  
Heart Surgery ◽  
Congenital Heart Surgery ◽  
Inhaled Nitric Oxide ◽  
Blind Study ◽  
Double Blind Study ◽  
Double Blind

scholarly journals Efficacy of inhaled nitric oxide in neonates with hypoxic respiratory failure and pulmonary hypertension: the Japanese experience

2018 ◽  
Vol 46 (6) ◽  
pp. 657-663 ◽  
Author(s):  
Satoshi Suzuki ◽  
Hajime Togari ◽  
Jim L. Potenziano ◽  
Michael D. Schreiber
Keyword(s):  
Nitric Oxide ◽  
Pulmonary Hypertension ◽  
Respiratory Failure ◽  
Negative Impact ◽  
Survival Rates ◽  
Oxygenation Index ◽  
Inhaled Nitric Oxide ◽  
Preterm Neonates ◽  
Therapeutic Trial ◽  
Hypoxic Respiratory Failure

AbstractObjective:To analyze data from a registry of Japanese neonates with hypoxic respiratory failure associated with pulmonary hypertension (PH) to compare the effectiveness of inhaled nitric oxide (iNO) in neonates born <34 weeks vs. ≥34 weeks gestational age (GA).Materials and methods:iNO was administered according to approved Japanese product labeling. Study data were collected before iNO administration and at predefined intervals until discontinuation.Results:A total of 1,114 neonates were included (n=431, <34 weeks GA; n=675, ≥34 weeks GA; n=8, missing age data). Mean decrease from baseline oxygenation index (OI) was similar in both age groups. OI reduction was more pronounced in the <34 weeks subgroups with baseline OI ≥25. Survival rates were similar in the <34 weeks GA and ≥34 weeks GA groups stratified by baseline OI (OI<15, 89% vs. 93%; 15≤OI<25, 85% vs. 91%; 25≤OI≤40, 73% vs. 79%; OI>40, 64% vs. 66%).Conclusion:iNO improved oxygenation in preterm neonates as effectively as in late preterm and term neonates, without negative impact on survival. If clinically significant PH is present, as measured by pulse oximetry or echocardiography, a therapeutic trial of iNO might be indicated for preterm neonates.

Inhaled nitric oxide in the prevention of pulmonary hypertension after congenital heart surgery

2000 ◽  
Vol 9 (3) ◽  
pp. A93
Author(s):  
O.I. Miller ◽  
T.S. Fong ◽  
A. Keech ◽  
N.B. Pigott ◽  
E. Beller ◽  
...  
Keyword(s):  
Nitric Oxide ◽  
Pulmonary Hypertension ◽  
Congenital Heart ◽  
Heart Surgery ◽  
Congenital Heart Surgery ◽  
Inhaled Nitric Oxide
Sign in / Sign up

Export Citation Format

Share Document